Transformation of mouse T cells requires MYC and AKT activity in conjunction with inhibition of intrinsic apoptosis

Oncotarget
Kari HögstrandAlf Grandien

Abstract

Peripheral T-cell lymphoma is an aggressive non-Hodgkin's lymphoma characterized by excessive proliferation of transformed mature T cells. The number and nature of genetic aberrations required and sufficient for transformation of normal T cells into lymphomas is unknown. Here, using a combinatorial in vitro-approach, we demonstrate that overexpression of MYC together with activated AKT in conditions of inhibition of intrinsic apoptosis rapidly resulted in transformation of mature mouse T cells with a frequency approaching 100%. Injection of transformed cells into mice resulted in rapid development of aggressive T cell lymphoma, characterized by spread to several organs, destruction of tissue architecture and rapid death of the animals. TcR-sequencing revealed a polyclonal repertoire of tumor cells indicating that co-expression of MYC, activated AKT and BCLXL is sufficient for tumor transformation and do not require acquisition of additional genetic events. When analyzing cells with inducible expression we found that proliferation of transformed T cells required sustained expression of both MYC and AKT. AKT exerted a dual function as it inhibited induction of, and promoted exit from, cellular quiescence and contributed to inhibi...Continue Reading

References

Mar 15, 1997·Genes & Development·S G KennedyN Hay
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·C M CounterR A Weinberg
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·S RamaswamyW R Sellers
Dec 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·S MalstromP N Tsichlis
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Apr 30, 2003·Nature·Tannishtha ReyaIrving L Weissman
May 20, 2003·The Journal of Pathology·George Z RassidakisL Jeffrey Medeiros
Jul 10, 2003·Cell Cycle·Jiyong Liang, Joyce M Slingerland
Jan 23, 2004·Nature Reviews. Cancer·Annapoorni Rangarajan, Robert A Weinberg
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Penelope J SwansonTimothy W Behrens
Nov 9, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Isabelle BardeOlivier Danos
Nov 24, 2005·Blood·Mauricio P OyarzoGeorge Z Rassidakis
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jean J ZhaoThomas M Roberts
Jan 21, 2006·Cancer Research·Naoki MoritoSatoru Takahashi
Mar 4, 2006·Stem Cells·Xiaobing YuCurt I Civin
Jun 10, 2006·Cell Death and Differentiation·S ZinkelE Yang
Apr 5, 2007·Nature Protocols·Carlo Riccardi, Ildo Nicoletti
Sep 14, 2007·Scandinavian Journal of Immunology·M DjerbiA Grandien
Jun 21, 2008·Blood·Sebastian NewrzelaDorothee von Laer
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie VoseUNKNOWN International T-Cell Lymphoma Project
Aug 30, 2008·Journal of Clinical Pathology·C AgostinelliS A Pileri
Oct 27, 2010·Human Cell·Hans G Drexler, Roderick A F Macleod
Sep 20, 2011·The Journal of Clinical Investigation·Xi WangCharles W M Roberts
Jan 6, 2012·The New England Journal of Medicine·Lucile CouronnéOlivier A Bernard
Apr 3, 2012·Cell·Chi V Dang
May 31, 2012·Leukemia·S NewrzelaD von Laer
May 3, 2013·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkGreg Eley

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
Assay
flow cytometry
PCR
dissection

Software Mentioned

Immunoseq
FlowJo
ImmunoSEQ Analyser

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.